PMC:7299399 / 15418-15728
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T63 | 141-147 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T64 | 288-298 | Disease | denotes | infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T169 | 113-116 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T19 | 141-147 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T71 | 0-310 | Sentence | denotes | The advantages of the capabilities of nanotechnology and nanomaterials for combined therapeutics and diagnostics has been widely explored in cancer research; however, there have been considerable efforts in the past few years to extend the scope of this approach to other areas including infectious diseases.58 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 246 | 141-147 | Disease | denotes | cancer | MESH:D009369 |
| 247 | 288-307 | Disease | denotes | infectious diseases | MESH:D003141 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32519842-30599229-158484 | 308-310 | 30599229 | denotes | 58 |